Autres langues Champions Oncology, Inc.

Actions

CSBR

US15870P3073

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
5,02 ^USD	-0,79 %		-0,79 %	-10,67 %

13/03	CHAMPIONS ONCOLOGY, INC. : Craig-Hallum neutre sur le dossier	ZM
12/03	Champions Oncology, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois clos le 31 janvier 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	15/03
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	12/03
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation	08/03
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	13/12
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	12/12
MORNING BID AMERICAS-Disinflation station	12/12
North American Morning Briefing : Traders Eye -2-	12/12
Champions Oncology, Inc: Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001:2015-Akkreditierung und ATS-Zertifizierung	02/11
Champions Oncology, Inc.	02/11
Champions Oncology Announces the Addition of Brady Davis as President	18/10/23
Champions Oncology, Inc. Appoints Brady Davis as President	17/10/23
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	13/09/23
Champions Oncology : Reports Quarterly Revenue of $12.6 Million - Form 8-K	13/09/23
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	13/09/23
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies	02/08/23
Champions Oncology Enters Multiyear Deal With BioVolume to Better Evaluate Cancer Studies	01/08/23
Champions Oncology, Inc. Announces Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies	01/08/23
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	24/07/23
Champions Oncology, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	24/07/23
Champions Oncology, Inc. Reports Earnings Results for the Fourth Quarter Ended April 30, 2023	24/07/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Champions Oncology, Inc.

Actions

CSBR

US15870P3073

Autres langues

Filtres